Table 1

EMERALD study schedule of events

Baseline2 months postdischarge3–9 months postdischarge12 months postdischarge
Informed consentX
Part A
X*
Part B
DemographicsX
IES-RXXX
CAPS-5, CGI-S*X*X*
PHQ-9XXX
GAD-7XXX
EQ-5D-5LXXX
EMDR interventionX*
IES-R, PHQ-9, GAD-7
(EMDR group only)
Randomisation preference*X*
Process evaluationXX
  • X* for participants consenting to part B of the study only.

  • CAPS-5, Clinician Administered PTSD Scale for DSM-5; CGI-S, Clinical Global Impression of Illness Severity; EMDR, eye-movement desensitisation and reprocessing; EQ-5D-5L, EuroQol-5 Dimensions-5 Levels; GAD-7, Generalised Anxiety Disorder 7; IES-R, Impact of Events Scale-Revised; PHQ-9, Patient Health Questionnaire-9; PTSD, post-traumatic stress disorder; QoL, quality of life; RCT, randomised controlled trial.